Bank of hot cells made by Von Gahlen will play a vital role in the production of important medical isotopes
Barcelona, Spain, October 12, 2022 /PRNewswire/ — SHINE Technologies and Von Gahlen International today announced that SHINE’s supercell has successfully passed Factory Acceptance Testing. The completion of these tests means that the supercell, a bank of 10 hot cells, is now being prepared for final shipment to The Chrysalis, SHINE’s large-scale medical isotope production facility in Janesville, Wis..
The supercell will house the key processes of production of medical isotopesincluding the extraction, purification and packaging of molybdenum-99 (Mo-99). The medical isotope is used for more than 40 million patient procedures per year worldwide, and the supercell will play a vital role in SHINE’s ability to produce up to 20 million doses of Mo-99 each year. Von Gahlen won the contract for the supercell based on its expertise in manufacturing critical solutions for nuclear medicine and radiopharmacy, its commitment to the SHINE project, and its alignment with SHINE’s core values.
“We are grateful to have been chosen to partner with this project and have taken on the challenge of producing something so unique,” said Jaap Duiker, CEO of Von Gahlen. “Knowing that this work could help up to 20 million patients potentially facing cancer or heart disease makes this project especially special. We look forward to continuing to work with SHINE and sharing their vision for a safer, healthier and cleaner world.
Installation of the supercell is also essential for SHINE to achieve substantial construction completion, a key milestone on the road to obtaining an operating license from the Nuclear Regulatory Commission. SHINE expects to receive this operating license in 2023.
“After seeing the supercell progress on recent trips to EuropeI’m glad it passed the tests and is about to Wisconsin. This marks another big step forward for the world’s first fusion facility dedicated solely to the production of medical isotopes, and towards much improved patient care in United States and all over the world,” said Greg Piefer, founder and CEO of SHINE. “I was very impressed with Von Gahlen’s ability to execute this complex and one-of-a-kind project, and am grateful for our continued partnership. They have set a new standard of excellence in hot cell construction, and We’re excited to put this system to work in the Chrysalis where it will produce up to a billion doses of medicine in its lifetime.”
SHINE also intends to use the learning and expertise gained during the construction of the medical isotope facility at Wisconsin to accelerate the construction of a sister facility in Veendam, the Netherlands.
“With this milestone, we are more confident of the timely completion of SHINE Europe’s production plant in Veendam, the Netherlandssaid Harrie Buurlage, Managing Director of SHINE Europe. “The sooner our facility in Veendam is ready, the sooner we can help millions of patients in Europe and the rest of the world.”
SHINE is a next-generation nuclear technology company, deploying cutting-edge fusion technology to create a scalable pathway to fusion power. Based in the south Wisconsinwhose head office is at Janesvilleand with a future site under development at Europe, SHINE deploys its safe, cost-effective and environmentally friendly technology in a phased approach. Our systems are used for industrial component imaging in the aerospace, defense, transportation, energy and other industries. And SHINE’s proprietary isotope production processes create unsupported molybdenum-99 and lutetium-177 used in tens of thousands of daily procedures to diagnose and treat heart disease and advanced cancers. For more information, follow SHINE on LinkedIn, Twitter and Facebook.
About Von Gahlen
Von Gahlen is a leading manufacturer of shielding solutions for nuclear medicine and radiopharmacy. Situated at the Netherlandswith sales offices also at United States and Germany, Von Gahlen offers standard or custom-made hot cells and a wide range of ancillary equipment for hot labs, as well as radiation-resistant radiopharmaceutical packaging, and more. For more, follow Von Gahlen on LinkedIn, Facebookand instagram.
YouTube link: https://www.youtube.com/watch?v=ZAcUSp1x_zQ
SOURCE SHINE Technologies, LLC